1. Home
  2. ATNI vs ABSI Comparison

ATNI vs ABSI Comparison

Compare ATNI & ABSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ATN International Inc.

ATNI

ATN International Inc.

HOLD

Current Price

$27.03

Market Cap

406.5M

ML Signal

HOLD

Logo Absci Corporation

ABSI

Absci Corporation

HOLD

Current Price

$5.11

Market Cap

357.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ATNI
ABSI
Founded
1987
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
406.5M
357.9M
IPO Year
1994
2021

Fundamental Metrics

Financial Performance
Metric
ATNI
ABSI
Price
$27.03
$5.11
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$6.96
AVG Volume (30 Days)
49.4K
5.1M
Earning Date
05-06-2026
05-07-2026
Dividend Yield
4.03%
N/A
EPS Growth
34.29
10.64
EPS
N/A
N/A
Revenue
$727,975,000.00
$4,534,000.00
Revenue This Year
$3.12
$215.96
Revenue Next Year
$1.10
$319.10
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$13.76
$2.24
52 Week High
$30.45
$6.72

Technical Indicators

Market Signals
Indicator
ATNI
ABSI
Relative Strength Index (RSI) 51.89 55.91
Support Level $21.15 $2.51
Resistance Level $27.66 $5.23
Average True Range (ATR) 1.26 0.57
MACD -0.01 -0.14
Stochastic Oscillator 78.55 28.03

Price Performance

Historical Comparison
ATNI
ABSI

About ATNI ATN International Inc.

ATN International Inc is a telecommunications and utilities company. The company provides digital infrastructure and communications services with a focus on rural and remote markets in the United States, and internationally, including Bermuda and the Caribbean region. Its operating segments comprise U.S. Telecom and International Telecom. The company earns revenue from its International telecommunication segment.

About ABSI Absci Corporation

Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.

Share on Social Networks: